Journal
JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 106, Issue 1, Pages 123-128Publisher
WILEY-BLACKWELL
DOI: 10.1016/j.xphs.2016.07.009
Keywords
amorphous; co-amorphous; glass transition temperature; enthalpy relaxation; intermolecular interaction; crystallization
Funding
- JSPS KAKENHI (Tokyo, Japan) [16K21500]
- Grants-in-Aid for Scientific Research [16K21500] Funding Source: KAKEN
Ask authors/readers for more resources
In this study, we investigated the formation of a co-amorphous system of tranilast (TRL) and diphenhydramine hydrochloride (DPH), which are drugs used for treating allergies and inflammation. The crystallization from undercooled melts of the drugs and drug mixtures was evaluated by thermal analysis. Both drugs in the amorphous state underwent crystallization on heating, although the mixture remained in the amorphous state, indicating the formation of a co-amorphous system. The physico-chemical properties of co-amorphous TRL-DPH prepared by the melting-cooling process were studied. The glass transition temperature of co-amorphous TRL-DPH deviated from the theoretical value. The enthalpy relaxation rate of the amorphous drugs, which reflected the molecular mobility, was reduced by the formation of a co-amorphous system. The intermolecular interactions between TRL and DPH in the co-amorphous system were measured by the change in the IR spectra. These results were consistent with the high physical stability. The co-amorphous sample remained in the amorphous state for over 30 days at 40 degrees C, whereas the amorphous drugs showed rapid crystallization. Our findings demonstrate that TRL and DPH form a co-amorphous system, which dramatically decreases their crystallization without an excipient. (C) 2016 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available